New Jersey A5530 mandates substance use disorder treatment centers to provide opioid antidotes to certain patients upon discharge.
New Jersey A5530 requires substance use disorder treatment centers to dispense at least two doses of an opioid antidote to patients with a history of opioid use, diagnosed opioid use disorder, or who have experienced an opioid-related overdose. This provision includes appropriate counseling and education on the antidote's use, to be documented in the patient's file. The Commissioner of Health, in consultation with the Commissioner of Human Services, will adopt necessary rules and regulations to implement this requirement.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.